FDA recalls thousands of faulty portable O2 systems

Safety label sign

The US Food and Drug Administration (FDA) has had to recall over one thousand portable oxygen (O2) devices from OxySure Therapeutics, Inc. after several device malfunctions were revealed, including ineffective O2 delivery and chemical reactions in the canisters that could cause them to explode.

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content online from just $270.